| Cat. No. |
CRP0892 |
| Product Overview |
Recombinant human OPG/Fc
produced in Pichia. P. contains 412 amino acid residues, including
180 residues from mature OPG (a.a 22-201) and 232 residues from the
Fc protein of human IgG1, and has a calculated molecular mass of
46.5 kDa. As a result of glycosylation, the recombinant OPG/Fc
migrates as a 49 kDa protein in SDS-PAGE under reducing conditions. |
| Description |
Osteoprotegerin (OPG)
is a member of the TNFR superfamily that can act as a decoy receptor
for RANKL. Binding of soluble OPG to sRANKL inhibits
osteoclastogenesis by interrupting the signaling between stromal
cells and osteoclastic progenitor cells, thereby leading to excess
accumulation of bone and cartilage. OPG is expressed in a wide
variety of tissues including adult heart, lung, kidney, liver,
spleen, prostate, lymph node and bone marrow. OPG is secreted both
as a monomeric and a dimeric protein. Its primary structure consists
of seven distinct domains, four of which corresponds to the
extracellular cysteine-rich domains of TNFR proteins and constitutes
the soluble OPG. |
| Purity |
>90% by SDS-PAGE and
HPLC analyses. |
| Specific Activity |
Fully biologically
active when compared to the standard. Determined by its ability to
neutralize the stimulation of U937 cells treated with 10 ng/ml of
soluble RANKL. |
| Formulation |
Lyophilized from a
0.2μm filtered concentrated (0.5mg/ml) solution in PBS, pH 7.4. |
| Endotoxin |
Less than 1EU/μg of
rHuOPG-Fc as determined by LAL method. |
| Reconstitution |
We recommend that
this vial be briefly centrifuged prior to opening to bring the
contents to the bottom. Reconstitute in sterile distilled water or
aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL.
Stock solutions should be apportioned into working aliquots and
stored at ≤20°C. Further dilutions should be made in appropriate
buffered solutions. |
| Storage |
This lyophilized
preparation is stable at 2-8°C, but should be kept at -20°C for long
term storage, preferably desiccated. Upon reconstitution, the
preparation is stable for up to one week at 2-8°C. For maximal
stability, apportion the reconstituted preparation into working
aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw
cycles. |
| Gene Information |
Gene Name |
TNFRSF11B |
|
Synonyms |
OPG; TR1; OCIF; MGC29565; Osteoprotegerin;
osteoclastogenesis inhibitory factor; Tumor necrosis factor receptor
superfamily member 11B; Tumor necrosis factor receptor superfamily
member 11B Precursor |
|
GeneID |
4982 |
|
mRNA Refseq |
NM_002546 |
|
Protein Refseq |
NP_002537 |
|
MIM |
602643 |
|
UniProt ID |
O00300 |
|
Chromosome Location |
8q24 |
|
Pathway |
Cytokine-cytokine receptor interaction |
|
Function |
cytokine activity; protein binding; receptor
activity |
|
|
Download Datasheet
 |
|
|
|